Improved Detection of Urothelial Carcinoma In Situ With Hexaminolevulinate Fluorescence Cystoscopy
- 1 January 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 171 (1), 135-138
- https://doi.org/10.1097/01.ju.0000100480.70769.0e
Abstract
In this European multicenter study we compared hexaminolevulinate (HAL) fluorescence cystoscopy and standard white light cystoscopy for the detection of carcinoma in situ (CIS) in patients suspected of having high risk bladder cancer. This study was a prospective controlled, within-patient comparison of standard and HAL fluorescence cystoscopy. Eligible patients received an intravesical instillation of 50 ml HAL 8 mM solution. Cystoscopy was performed using a D light system, which provided white and blue light at 375 to 440 nm. The bladder wall was inspected and mapped, first under white light, followed by blue light. All tumors and suspicious areas identified under white light and by red fluorescence were resected or biopsied. Histological findings were assessed by an independent central pathologist blinded to the identity of the biopsies. Of 211 evaluable patients 83 (39%) had CIS, of whom 18 (22%) were detected by HAL cystoscopy only, 62 (75%) were detected by standard and HAL cystoscopy, 2 (2%) were detected by standard cystoscopy only and 1 (1%) was detected by nonguided biopsy. Therefore, HAL cystoscopy identified 28% more patients with CIS than standard cystoscopy. The side effects of HAL instillation were negligible and no unexpected events were reported. HAL fluorescence cystoscopy improves the detection of bladder CIS significantly, which has consequences for clinical management and may improve the patient prognosis. The procedure is easily implemented as an adjunct to standard cystoscopy and it adds no significant risk of complications.Keywords
This publication has 17 references indexed in Scilit:
- Clinically Relevant Improvement of Recurrence-free Survival with 5-Aminolevulinic Acid Induced Fluorescence Diagnosis in Patients with Superficial Bladder TumorsJournal of Urology, 2002
- Clinical Panurothelial Disease in Patients with Superficial Bladder Tumors: Therapeutic ImplicationsJournal of Urology, 2002
- Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopiesUrology, 2001
- Preventing progression and improving survival with BCG maintenance.European Urology, 2000
- Effect of Vitamins on the Lipid Profile of Patients on Regular HemodialysisScandinavian Journal of Urology and Nephrology, 2000
- Survival of patients with carcinoma in situ of the urinary bladderCancer, 1999
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderThe American Journal of Surgical Pathology, 1998
- CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?Journal of Urology, 1998
- Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into ProtoporphyrinPhotochemistry and Photobiology, 1998
- Fluorescence detection of bladder carcinomaUrology, 1997